Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITK | Q08881 | 18/20 | 0.69 |
| ▸ | TEC | P42680 | 1/20 | 0.53 |
| ▸ | TXK | P42681 | 1/20 | 0.53 |
| ▸ | INSR | P06213 | 2/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6632540 | 0.88 | ITK (0.72) | ITKTECTXKINSROPRK1 | |
| SCHEMBL6766640 | 0.86 | ITK (0.92) | ITKTECTXK | |
| SCHEMBL6770253 | 0.76 | ITK (1.00) | ITK | |
| SCHEMBL6771407 | 0.76 | ITK (0.88) | ITKTECTXK | |
| Hydrochloric Acid SCHEMBL8026086 | 0.75 | CNR2 (0.49) | — | |
| SCHEMBL8026960 | 0.75 | CNR2 (0.51) | ITK | |
| SCHEMBL6770839 | 0.74 | ITK (0.82) | ITKTECTXK | |
| SCHEMBL6771435 | 0.74 | ITK (0.82) | ITKTECTXK | |
| SCHEMBL6632543 | 0.74 | ITK (1.00) | ITKTECTXK | |
| SCHEMBL6771576 | 0.73 | ITK (0.71) | ITKINSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6825219-B2 | NITROGEN COMPOUNDS SUCH AS 4-((5-(CYCLOHEXYL-METHYL-CARBAMOYL) -2(THIOPHENE-2-CARBONYL)-AMINO)BENZIMIDAZOL-1-YL)-BUTYRIC ACID ADMINISTERED FOR THE PROPHYLAXIS OF INFLAMMATORY, IMMUNOLOGICAL AND ALLERGIC DISORDERS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2004-11-30 | — | — | US | disclosed |